Search - tctmd.com

Displaying 301 - 320 of 955

Sort: Relevancy | Date

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

News Conference News PCR London Valves 2019

Pulmonary Hypertension, Common in TAVR Patients, Linked to Lower Survival

Michael O'Riordan

November 26, 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

News Conference News PCR London Valves 2019

Solid 2-Year Outcomes for Portico, With Paravalvular Leak Rare

Michael O'Riordan

November 20, 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

News Conference News AHA 2019

TAVR Valve Face-off: Two French Observational Studies Suggest Inherent Differences

Yael L. Maxwell

November 18, 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

News Conference News AHA 2019

Full GALILEO Results Confirm Harm With Rivaroxaban After TAVR

November 17, 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

News Conference News AHA 2019

Early Surgery Beats a Conservative Approach in Asymptomatic AS: RECOVERY

Yael L. Maxwell

November 16, 2019

News Industry News

Edwards SAPIEN 3 TAVI Receives Expanded Approval In Europe

November 06, 2019

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

News Daily News

Better Survival 3 Years After TAVR for Patients With Mixed Aortic Valve Disease

November 01, 2019

TCTMD’s Top 10 Most Popular Stories for October 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2019

October 31, 2019

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

News Daily News

Gaps in Access to TAVR and SAVR: ‘Something Needs to Be Done’

October 29, 2019

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

News Daily News

Cardiac Rehab Tied to Fewer Hospitalizations, Deaths After Valve Surgery

October 23, 2019

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

News Daily News

New-Onset A-fib Tied to Particularly Poor Outcomes After TAVR

October 18, 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

News Conference News TCT 2019

Early Mortality Rates After TAVR Halved in a Decade, With Some Gender Differences

October 09, 2019

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

News Daily News

PARTNER 2A at EACTS 2019: ‘The Message Is Exactly the Same’

October 08, 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

News Conference News TCT 2019

MitraClip Pricey but ‘Acceptable’ in COAPT Cost-Efficacy Analysis

September 29, 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

News Conference News TCT 2019

TAVR Improves Health Status Over Surgery in Low-Risk Patients at 1 Year: PARTNER 3

Yael L. Maxwell

September 29, 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

News Conference News TCT 2019

Long-term PARTNER 2A Results Put Spotlight on Paravalvular Leak in TAVR

September 29, 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

News Conference News TCT 2019

Leave It Be: PCI for Stable CAD Before or With TAVR Does Not Lower Mortality Risk

Michael O'Riordan

September 29, 2019

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

News Daily News

Surgical Bailout Rarely Needed Though Can Save Lives: TVT Registry

Yael L. Maxwell

September 18, 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

News Conference News ESC 2019

Mortality in Untreated Moderate AS Keeps Pace With What’s Seen in More Severe Disease

September 05, 2019

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

News Daily News

MIDAS Touch: Anatomic Strategy Dramatically Lowers Pacemaker Rate With Evolut Valves

Michael O'Riordan

August 29, 2019

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.